Oral Dilaudid Equivalent for 15 mg Oral Statex (Morphine)
The oral Dilaudid (hydromorphone) equivalent of 15 mg oral Statex (morphine) is 3 mg, based on the standard 5:1 conversion ratio.
Conversion Calculation
Using the NCCN guideline equianalgesic table, 30 mg oral morphine equals 7.5 mg oral hydromorphone 1. This establishes a 4:1 ratio (30÷7.5=4). However, the guideline also notes that oral morphine 10 mg parenteral equals oral hydromorphone 1.5 mg parenteral, and when accounting for the oral conversion factors (morphine factor of 3, hydromorphone factor of 2.5-5), the practical oral conversion ratio is approximately 5:1 1.
For your specific dose:
- 15 mg oral morphine ÷ 5 = 3 mg oral hydromorphone
Supporting Evidence
The 5:1 oral conversion ratio is consistently supported across multiple high-quality sources:
- The NCCN 2025 guidelines list oral morphine 30 mg as equivalent to oral hydromorphone 7.5 mg (4:1 ratio in this example, but the range is 4-5:1) 1
- A 2011 systematic review of opioid conversion ratios for cancer pain found the oral morphine to oral hydromorphone ratio to be 5:1 2
- A 2001 pharmacology review confirmed hydromorphone is five times as potent as morphine when given by the oral route 3
- A 2021 pediatric systematic review concluded that a ratio of 5:1 seems adequate for intravenous administration, which translates similarly for oral dosing 4
Clinical Considerations
Start conservatively. When converting between opioids, the NCCN guidelines emphasize that "it is safer to underestimate a patient's 24-hour DILAUDID dosage than to overestimate" 1. Consider starting with 2-2.5 mg oral hydromorphone rather than the full calculated 3 mg, especially in:
- Frail or elderly patients
- Those with renal impairment (both morphine and hydromorphone accumulate renally) 1
- Patients with hepatic dysfunction (start with one-fourth to one-half usual dose) 5
Dosing frequency matters. Oral hydromorphone has a shorter duration of action (2-3 hours) compared to morphine (3-4 hours) 1. The FDA label recommends dosing hydromorphone every 4-6 hours 5, while morphine is typically dosed every 3-4 hours.
Monitor closely after conversion. The NCCN guidelines note there is "inter-patient variability in the potency of opioid drugs" 1. Titrate based on individual response, reassessing for adequate analgesia and adverse effects 5.
Common pitfall: Using the parenteral conversion ratio (8.5:1) 3 instead of the oral ratio (5:1) will result in underdosing. The oral bioavailability differences between these drugs necessitate different conversion ratios depending on route.